Robin Hood Ventures is an angel investor group based in Philadelphia, Pennsylvania, established in 1999. The organization focuses on early-stage, high-growth companies primarily in the Greater Philadelphia region. It provides capital, mentoring, and valuable connections to assist entrepreneurs in building successful businesses. Typically, Robin Hood Ventures invests between $250,000 and $500,000, often collaborating with other angel investors, institutions, and venture capitalists within its network. The firm has a diverse investment portfolio, spanning various sectors, including information technology services, software, life sciences, hard technology, consumer products, and financial technology. Since its inception, Robin Hood Ventures has invested in over 45 companies, emphasizing a hands-on approach to helping businesses achieve their potential.
Deepwave Digital, Inc. specializes in manufacturing artificial intelligence (AI)-based hardware and software solutions tailored for radio frequency (RF) and wireless systems. Established in 2017 and headquartered in Philadelphia, Pennsylvania, the company provides integrated solutions that enhance the capabilities of RF systems by relocating the AI computation engine closer to the signal edge. This innovative approach minimizes network bandwidth usage, reduces latency, and decreases reliance on manual analysis. Deepwave Digital's product lineup includes the Artificial Intelligence Radio Transceiver (AIR-T), a software-defined radio, as well as software tools like AirPack, AirStack Sandbox, and Spectrum Sensing, which help clients detect and identify signals in their spectral environment. With a team of RF industry experts boasting over fifty years of combined experience, Deepwave Digital serves both commercial and defense sectors, enabling customers to develop custom AI and high-performance computing systems using trusted software solutions.
Proscia
Series C in 2024
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
Biomeme
Convertible Note in 2024
Biomeme Inc., founded in 2012 and based in Philadelphia, Pennsylvania, offers an innovative platform for molecular DNA diagnostics and on-site disease tracking through a smartphone. The company's technology includes a real-time PCR thermocycler that connects to an iPhone, alongside a docking station and a mobile app for controlling the system and analyzing results. Biomeme provides targeted test kits that allow users to prepare samples and identify pathogens or diseases based on their specific DNA or RNA signatures. This end-to-end DNA testing solution enables mobile testing at the point-of-need across various sectors, including healthcare, agriculture, veterinary medicine, environmental monitoring, and education. By facilitating lab-grade molecular processes, Biomeme enhances real-time disease surveillance and diagnostics.
ChargeItSpot
Series A in 2023
ChargeItSpot, LLC offers cell phone charging stations and kiosks across the United States and Canada. Founded in 2011 and headquartered in Philadelphia, Pennsylvania, the company provides free and secure charging solutions that enhance customer engagement in various locations, including retail stores, malls, casinos, stadiums, hospitals, and at events such as conferences and festivals. ChargeItSpot's stations are equipped with a touchscreen interface, secure locking capability, and customizable on-screen messages, as well as features for data tracking and reporting. These charging stations not only serve the practical need for device charging but are also designed to increase sales and customer traffic, making them a valuable asset for brands and retailers.
Lia
Convertible Note in 2023
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.
LuxTech
Convertible Note in 2023
LUXTECH, LLC is a Philadelphia-based company that specializes in designing, engineering, and manufacturing LED module solutions for lighting fixture manufacturers. Established in 2012, the company focuses on specification-grade LED modules, which include a range of products such as LINEAR Dynamic White, COB Warm Dim, and FLEX LED modules. LUXTECH caters to various industries, including entertainment, education, healthcare, and cultural sectors, by providing modules that support human-centric architectural lighting applications. The company assists original equipment manufacturers (OEMs) in rapidly developing reliable, energy-efficient LED fixtures to meet market demands. With a commitment to innovation and efficiency, LUXTECH also offers custom designs and consultation services, enabling partners to retrofit existing fixtures or create new ones. Their products are designed for diverse applications such as troffers, downlights, and outdoor lighting, featuring long lifetimes and low energy consumption. LUXTECH’s LED modules are built using high-quality components, backed by a five-year warranty, ensuring reliability and performance in the lighting industry.
Proscia
Series C in 2022
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
Atrin Pharmaceuticals
Venture Round in 2022
Atrin Pharmaceuticals LLC is a biopharmaceutical company based in Doylestown, Pennsylvania, focused on the discovery and development of innovative cancer treatments. Founded in 2011, the company is developing its lead drug candidates, ATRN-502, a p53 activator, and ATRN-507, a dual ligand that selectively targets cancer cells. Atrin is also advancing a proprietary platform called Atrize, which utilizes phenotypic FACS-based screening for rapid identification of effective drug candidates and evaluation of personalized medicine approaches. The company's research aims to address cancers linked to synthetic lethality and deregulated DNA damage response, with a focus on creating treatments that are effective against cancer cells while minimizing impact on healthy cells. Through its innovative methodologies, Atrin Pharmaceuticals seeks to change the landscape of cancer therapy.
ChargeItSpot
Venture Round in 2022
ChargeItSpot, LLC offers cell phone charging stations and kiosks across the United States and Canada. Founded in 2011 and headquartered in Philadelphia, Pennsylvania, the company provides free and secure charging solutions that enhance customer engagement in various locations, including retail stores, malls, casinos, stadiums, hospitals, and at events such as conferences and festivals. ChargeItSpot's stations are equipped with a touchscreen interface, secure locking capability, and customizable on-screen messages, as well as features for data tracking and reporting. These charging stations not only serve the practical need for device charging but are also designed to increase sales and customer traffic, making them a valuable asset for brands and retailers.
Lia
Seed Round in 2022
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.
Deepwave Digital
Seed Round in 2020
Deepwave Digital, Inc. specializes in manufacturing artificial intelligence (AI)-based hardware and software solutions tailored for radio frequency (RF) and wireless systems. Established in 2017 and headquartered in Philadelphia, Pennsylvania, the company provides integrated solutions that enhance the capabilities of RF systems by relocating the AI computation engine closer to the signal edge. This innovative approach minimizes network bandwidth usage, reduces latency, and decreases reliance on manual analysis. Deepwave Digital's product lineup includes the Artificial Intelligence Radio Transceiver (AIR-T), a software-defined radio, as well as software tools like AirPack, AirStack Sandbox, and Spectrum Sensing, which help clients detect and identify signals in their spectral environment. With a team of RF industry experts boasting over fifty years of combined experience, Deepwave Digital serves both commercial and defense sectors, enabling customers to develop custom AI and high-performance computing systems using trusted software solutions.
Proscia
Series B in 2020
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
Wash Cycle Laundry
Series A in 2020
Wash Cycle Laundry Inc. is a Philadelphia-based company that offers laundry, linen rental, and dry cleaning services for both residential and commercial clients. Established in 2012, the company provides a range of services, including washing clothes, sheets, towels, and janitorial supplies, along with campus laundry plans and managed on-premise laundry solutions. It caters to a diverse clientele, including universities, hospitals, hotels, fitness centers, and individual customers. Notably, Wash Cycle Laundry distinguishes itself by using eco-friendly detergents and non-toxic solvents for its cleaning processes, avoiding harmful chemicals commonly used in the industry. The company also operates an additional location in Washington, D.C., and is committed to sustainable practices in its operations.
ExpressCells
Venture Round in 2020
ExpressCells, Inc. is a biotechnology company based in Philadelphia, Pennsylvania, established in 2018 by Oscar Perez-Leal and Matt Handel. The firm specializes in genetic engineering to develop custom knock-in cell lines that facilitate drug discovery and biological research. Utilizing advanced gene-editing technology, ExpressCells makes precise modifications to a cell's genome, enabling the insertion of new genes through a patent-pending plasmid system. This innovative approach allows researchers to visualize proteins and organelles within cells, providing valuable insights that enhance disease modeling and accelerate drug development efforts.
Yellowdig
Convertible Note in 2020
Yellowdig is a software platform that enhances peer learning outcomes by creating a social layer on top of existing enterprise learning systems utilized by colleges, universities, and organizations. Established in 2015 and based in Philadelphia, Pennsylvania, Yellowdig focuses on providing a private and secure experience tailored for higher education institutions. The platform fosters collaborative learning environments, encouraging student engagement and retention while enhancing their understanding of current affairs. By integrating with established learning systems, Yellowdig transforms traditional classrooms into vibrant learning communities.
Biomeme
Convertible Note in 2020
Biomeme Inc., founded in 2012 and based in Philadelphia, Pennsylvania, offers an innovative platform for molecular DNA diagnostics and on-site disease tracking through a smartphone. The company's technology includes a real-time PCR thermocycler that connects to an iPhone, alongside a docking station and a mobile app for controlling the system and analyzing results. Biomeme provides targeted test kits that allow users to prepare samples and identify pathogens or diseases based on their specific DNA or RNA signatures. This end-to-end DNA testing solution enables mobile testing at the point-of-need across various sectors, including healthcare, agriculture, veterinary medicine, environmental monitoring, and education. By facilitating lab-grade molecular processes, Biomeme enhances real-time disease surveillance and diagnostics.
LoanLogics
Convertible Note in 2020
LoanLogics, Inc. is a provider of innovative mortgage loan software products and services aimed at enhancing the efficiency and quality of the mortgage industry. Based in Trevose, Pennsylvania, the company offers several key platforms, including LoanDecisions for product eligibility and mortgage pricing, and LoanHD for real-time loan quality management. Its solutions are designed to automate key processes, thereby reducing loan defects and costs while managing risks in the manufacturing, acquisition, and sale of loan assets. LoanLogics serves a diverse clientele, including residential mortgage lenders, servicers, insurers, and investors, and has established strategic partnerships to enhance its offerings. Founded in 2006 and originally named Aklero Risk Analytics, LoanLogics rebranded in 2013 to reflect its focus on comprehensive mortgage solutions.
Immunome
Series A in 2020
Immunome Inc., founded in 2006 and headquartered in Exton, Pennsylvania, is a biotechnology company focused on discovering, developing, and commercializing highly targeted and native human cancer antibodies against universal cancer antigens. The company utilizes its proprietary RealMAb technology to identify novel antigens and the corresponding native human antibodies that target them. Additionally, Immunome employs ScreenMab multiplex functional screening technology to pinpoint monoclonal antibodies with high specificity for tumor neoantigens.
Lia
Convertible Note in 2020
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.
Annovis Bio
Post in 2020
Annovis Bio, Inc. is a clinical-stage pharmaceutical company based in Berwyn, Pennsylvania, specializing in the development of treatments for neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease. The company is advancing several compounds in clinical trials, with its lead candidate, ANVS401, currently in Phase 2a trials aimed at treating Alzheimer’s disease, Parkinson’s disease, and other chronic neurodegenerative conditions. Additionally, Annovis is developing ANVS405, which focuses on providing neuroprotection following traumatic brain injuries and strokes, and ANVS301, which is in Phase I trials designed to enhance cognitive function in later stages of Alzheimer’s disease and dementia. Founded in 2008, Annovis Bio is dedicated to creating innovative therapies to address the challenges posed by these debilitating diseases.
Immunome
Series A in 2019
Immunome Inc., founded in 2006 and headquartered in Exton, Pennsylvania, is a biotechnology company focused on discovering, developing, and commercializing highly targeted and native human cancer antibodies against universal cancer antigens. The company utilizes its proprietary RealMAb technology to identify novel antigens and the corresponding native human antibodies that target them. Additionally, Immunome employs ScreenMab multiplex functional screening technology to pinpoint monoclonal antibodies with high specificity for tumor neoantigens.
KickUp
Series A in 2019
KickUp, Inc. operates a collaboration platform tailored for K-12 school districts, focusing on the design, coordination, and assessment of professional learning activities. The platform provides educational leaders with actionable insights into the effectiveness of their programs, allowing for informed decision-making. It enables professional development teams to leverage analytics for customizing support for teachers, aligning with strategic goals, and integrating real-time data from surveys. KickUp's services aim to enhance the professional learning experience, ensuring that innovative ideas translate into measurable outcomes in the classroom. Founded in 2014 and headquartered in Philadelphia, Pennsylvania, the company was previously known as Pedagology, LLC before rebranding in 2015.
WizeHive
Convertible Note in 2019
WizeHive, Inc. is a technology company that specializes in developing and operating cloud-based software platforms designed to help organizations streamline their business processes. Founded in 2009 and based in Conshohocken, Pennsylvania, WizeHive offers a range of software solutions including grants management, scholarship management, awards management, fellowship management, internship management, and accreditation management systems. These tools facilitate the collection, review, and organization of applications and records for various programs, catering to foundations, universities, and government agencies. WizeHive's flagship product, Zengine, is a user-friendly platform that enables non-technical users to build custom applications while allowing developers to enhance functionality through integrations and plugins. By automating administrative tasks and improving organizational efficiency, WizeHive helps its clients save time and resources.
Wash Cycle Laundry
Convertible Note in 2019
Wash Cycle Laundry Inc. is a Philadelphia-based company that offers laundry, linen rental, and dry cleaning services for both residential and commercial clients. Established in 2012, the company provides a range of services, including washing clothes, sheets, towels, and janitorial supplies, along with campus laundry plans and managed on-premise laundry solutions. It caters to a diverse clientele, including universities, hospitals, hotels, fitness centers, and individual customers. Notably, Wash Cycle Laundry distinguishes itself by using eco-friendly detergents and non-toxic solvents for its cleaning processes, avoiding harmful chemicals commonly used in the industry. The company also operates an additional location in Washington, D.C., and is committed to sustainable practices in its operations.
ExpressCells
Series A in 2019
ExpressCells, Inc. is a biotechnology company based in Philadelphia, Pennsylvania, established in 2018 by Oscar Perez-Leal and Matt Handel. The firm specializes in genetic engineering to develop custom knock-in cell lines that facilitate drug discovery and biological research. Utilizing advanced gene-editing technology, ExpressCells makes precise modifications to a cell's genome, enabling the insertion of new genes through a patent-pending plasmid system. This innovative approach allows researchers to visualize proteins and organelles within cells, providing valuable insights that enhance disease modeling and accelerate drug development efforts.
Lia
Seed Round in 2018
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.
Proscia
Series A in 2018
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
Annovis Bio
Series A in 2016
Annovis Bio, Inc. is a clinical-stage pharmaceutical company based in Berwyn, Pennsylvania, specializing in the development of treatments for neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease. The company is advancing several compounds in clinical trials, with its lead candidate, ANVS401, currently in Phase 2a trials aimed at treating Alzheimer’s disease, Parkinson’s disease, and other chronic neurodegenerative conditions. Additionally, Annovis is developing ANVS405, which focuses on providing neuroprotection following traumatic brain injuries and strokes, and ANVS301, which is in Phase I trials designed to enhance cognitive function in later stages of Alzheimer’s disease and dementia. Founded in 2008, Annovis Bio is dedicated to creating innovative therapies to address the challenges posed by these debilitating diseases.
UniRisX
Debt Financing in 2016
Unirisx, LLC specializes in providing Software-as-a-Service (SaaS) solutions tailored for insurers, brokers, and intermediaries to effectively launch, distribute, and manage insurance products globally. The company offers a comprehensive Unirisx Solution Suite, which includes policy administration and underwriting technology that supports various insurance lines such as personal, commercial, and specialty insurance. Key offerings include the Unirisx Underwriting Center, which streamlines the underwriting process by prioritizing tasks and facilitating collaboration, and the Unirisx Agency/Broker Center, which enables agile management of insurance operations with real-time performance insights. Additionally, Unirisx covers specialized solutions for coverholders and direct-to-consumer channels, ensuring efficient quoting, binding, and policy administration. Founded in 2009 and headquartered in Philadelphia, Pennsylvania, with offices in the UK and Malaysia, Unirisx serves clients across Asia, EMEA, and the United States, constantly evolving its platform to meet the diverse needs of the global insurance market.
Proscia
Seed Round in 2016
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
ChargeItSpot
Series A in 2016
ChargeItSpot, LLC offers cell phone charging stations and kiosks across the United States and Canada. Founded in 2011 and headquartered in Philadelphia, Pennsylvania, the company provides free and secure charging solutions that enhance customer engagement in various locations, including retail stores, malls, casinos, stadiums, hospitals, and at events such as conferences and festivals. ChargeItSpot's stations are equipped with a touchscreen interface, secure locking capability, and customizable on-screen messages, as well as features for data tracking and reporting. These charging stations not only serve the practical need for device charging but are also designed to increase sales and customer traffic, making them a valuable asset for brands and retailers.
ChargeItSpot
Series A in 2015
ChargeItSpot, LLC offers cell phone charging stations and kiosks across the United States and Canada. Founded in 2011 and headquartered in Philadelphia, Pennsylvania, the company provides free and secure charging solutions that enhance customer engagement in various locations, including retail stores, malls, casinos, stadiums, hospitals, and at events such as conferences and festivals. ChargeItSpot's stations are equipped with a touchscreen interface, secure locking capability, and customizable on-screen messages, as well as features for data tracking and reporting. These charging stations not only serve the practical need for device charging but are also designed to increase sales and customer traffic, making them a valuable asset for brands and retailers.
Lia
Seed Round in 2015
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.
OneTwoSee
Debt Financing in 2015
OneTwoSee is a Philadelphia-based company specializing in the development of sports game-centers that enhance fan engagement through real-time statistics, game data, advanced analytics, and social media integration. It offers licensed, white-labeled products that can be seamlessly incorporated into customers' branded websites and platforms, accessible across various devices such as PCs, tablets, smartphones, smart TVs, and in-arena displays. The company serves a diverse clientele, including regional and national sports networks, newspaper publishers, and consumer electronics firms, allowing them to effectively engage and monetize their audiences with high-value advertising and sponsorship opportunities. OneTwoSee's scalable technology platform enables partners to realize immediate returns on investment while delivering a rich, interactive experience for sports fans.
Annovis Bio
Series A in 2015
Annovis Bio, Inc. is a clinical-stage pharmaceutical company based in Berwyn, Pennsylvania, specializing in the development of treatments for neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease. The company is advancing several compounds in clinical trials, with its lead candidate, ANVS401, currently in Phase 2a trials aimed at treating Alzheimer’s disease, Parkinson’s disease, and other chronic neurodegenerative conditions. Additionally, Annovis is developing ANVS405, which focuses on providing neuroprotection following traumatic brain injuries and strokes, and ANVS301, which is in Phase I trials designed to enhance cognitive function in later stages of Alzheimer’s disease and dementia. Founded in 2008, Annovis Bio is dedicated to creating innovative therapies to address the challenges posed by these debilitating diseases.
Immunome
Debt Financing in 2015
Immunome Inc., founded in 2006 and headquartered in Exton, Pennsylvania, is a biotechnology company focused on discovering, developing, and commercializing highly targeted and native human cancer antibodies against universal cancer antigens. The company utilizes its proprietary RealMAb technology to identify novel antigens and the corresponding native human antibodies that target them. Additionally, Immunome employs ScreenMab multiplex functional screening technology to pinpoint monoclonal antibodies with high specificity for tumor neoantigens.
AlphaPoint
Seed Round in 2014
AlphaPoint Corporation, established in 2013, specializes in developing white-label software for digital asset trading platforms. Based in New York with additional offices in Philadelphia and San Francisco, the company empowers over 150 clients across 35 countries to launch and operate crypto exchanges, digitize assets, and execute blockchain strategies. AlphaPoint's secure, scalable, and customizable platform supports a wide range of digital currencies, including bitcoin and altcoins, and offers solutions such as a full digital currency exchange system, automatic market-making, asset digitization software, and a platform for high net worth clients to execute large block trades.
ChargeItSpot
Seed Round in 2014
ChargeItSpot, LLC offers cell phone charging stations and kiosks across the United States and Canada. Founded in 2011 and headquartered in Philadelphia, Pennsylvania, the company provides free and secure charging solutions that enhance customer engagement in various locations, including retail stores, malls, casinos, stadiums, hospitals, and at events such as conferences and festivals. ChargeItSpot's stations are equipped with a touchscreen interface, secure locking capability, and customizable on-screen messages, as well as features for data tracking and reporting. These charging stations not only serve the practical need for device charging but are also designed to increase sales and customer traffic, making them a valuable asset for brands and retailers.
OneTwoSee
Venture Round in 2014
OneTwoSee is a Philadelphia-based company specializing in the development of sports game-centers that enhance fan engagement through real-time statistics, game data, advanced analytics, and social media integration. It offers licensed, white-labeled products that can be seamlessly incorporated into customers' branded websites and platforms, accessible across various devices such as PCs, tablets, smartphones, smart TVs, and in-arena displays. The company serves a diverse clientele, including regional and national sports networks, newspaper publishers, and consumer electronics firms, allowing them to effectively engage and monetize their audiences with high-value advertising and sponsorship opportunities. OneTwoSee's scalable technology platform enables partners to realize immediate returns on investment while delivering a rich, interactive experience for sports fans.
Novira Therapeutics
Series A in 2013
Novira Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Doylestown, Pennsylvania, focused on discovering and developing antiviral drugs for chronic hepatitis B (HBV) and human immunodeficiency virus (HIV) infections. The company specializes in creating first-in-class oral therapeutics that target the capsid of these viruses, offering potential treatment options that address significant limitations in current therapies. Novira's innovative capsid inhibitors can be used alone or in conjunction with existing treatments, aiming to overcome challenges such as drug resistance and the need for lifelong therapy, particularly in chronic HBV infection, where existing polymerase inhibitors are rarely curative. Founded in 2006, Novira Therapeutics operates as a subsidiary of Johnson & Johnson, reflecting its strategic importance in addressing global health needs related to antiviral treatment.
Novira Therapeutics
Seed Round in 2011
Novira Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Doylestown, Pennsylvania, focused on discovering and developing antiviral drugs for chronic hepatitis B (HBV) and human immunodeficiency virus (HIV) infections. The company specializes in creating first-in-class oral therapeutics that target the capsid of these viruses, offering potential treatment options that address significant limitations in current therapies. Novira's innovative capsid inhibitors can be used alone or in conjunction with existing treatments, aiming to overcome challenges such as drug resistance and the need for lifelong therapy, particularly in chronic HBV infection, where existing polymerase inhibitors are rarely curative. Founded in 2006, Novira Therapeutics operates as a subsidiary of Johnson & Johnson, reflecting its strategic importance in addressing global health needs related to antiviral treatment.
Compliance Assurance
Venture Round in 2011
Compliance Assurance Corporation specializes in on-demand governance, risk, and compliance solutions tailored specifically for the insurance industry. Founded in 2003 and based in Pittsburgh, Pennsylvania, the company offers products such as Compliance Assured Enterprise, which delivers compliance packages for insurance carriers and their extended enterprises, and Compliance Assured Producer Network, designed to equip Compliance Officers with essential tools for managing risks related to extended enterprise compliance. By streamlining governance, risk, and compliance processes, Compliance Assurance aims to reduce compliance costs, mitigate risks, and enhance visibility within the insurance sector.
Vuzit
Angel Round in 2008
Vuzit is a Philadelphia-based software company that specializes in providing a secure platform for sharing, viewing, and controlling sensitive documents and content online. As organizations face growing complexities and legal liabilities associated with digital document sharing, Vuzit addresses these challenges with enterprise-level solutions designed for both small businesses and multinational corporations. Their products, including the Vuzit DocuPub Platform, offer a robust set of APIs and tools that allow users to embed and manage over 40 different file types within websites and applications. With features aimed at enhancing access control and monitoring, Vuzit ensures that organizations can effectively manage sensitive information such as financial records, contracts, and medical data while mitigating risks associated with online distribution.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.